Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy

Retargeting the antigen-binding specificity of T cells to intracellular antigens that are degraded and presented on the tumor surface by engineering chimeric antigen receptor (CAR), also named TCR-like antibody CAR-T, remains limited. With the exception of the commercialized CD19 CAR-T for hematolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lichen, Yang, Xiaomei, Zhong, Dani, Xie, Shenxia, Shi, Wei, Li, Yangzi, Hou, Xiaoqiong, HuaYao, Zhou, Huihui, Zhao, Minlong, Ding, Ziqiang, Zhao, Xinyue, Mo, Fengzhen, Yin, Shihua, Liu, Aiqun, Lu, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492946/
https://www.ncbi.nlm.nih.gov/pubmed/32964055
http://dx.doi.org/10.1155/2020/2454907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492946/
https://www.ncbi.nlm.nih.gov/pubmed/32964055
http://dx.doi.org/10.1155/2020/2454907

Ejemplares similares